Claude Dufresne

Title: Claude Dufresne: Innovator in Leukotriene Antagonists

Introduction

Claude Dufresne is a notable inventor based in California, recognized for his contributions to the field of pharmacology. He holds a patent for quinoline leukotriene antagonists, which are significant in treating various medical conditions. His work has implications for anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective applications.

Latest Patents

Dufresne's patent, which includes compounds of Formula I, focuses on antagonists of the actions of leukotrienes. These compounds are particularly useful in treating conditions such as angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection. He has been granted 1 patent for this innovative work.

Career Highlights

Claude Dufresne is associated with Merck & Company, Inc., a leading pharmaceutical company known for its research and development in healthcare. His role at Merck has allowed him to contribute significantly to advancements in medical treatments.

Collaborations

Throughout his career, Dufresne has collaborated with esteemed colleagues, including Byron H. Arison and Thomas A. Baillie. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.

Conclusion

Claude Dufresne's work in developing leukotriene antagonists showcases his commitment to improving healthcare through innovative solutions. His contributions continue to impact the treatment of various medical conditions, highlighting the importance of research and collaboration in the field of pharmacology.